Background: This study compared two types of sedation in pregnant women receiving subarachnoid anaesthesia for elective Caesarean section. Methods: This prospective randomised study included 56 women. Patients were sedated with propofol (PROP group, n = 27) or midazolam (MID group, n = 29) via intravenous infusion after extraction of the foetus. The following parameters were assessed at five-minute intervals: degree of sedation, heart rate, arterial pressure, ECG recording and arterial haemoglobin oxygen saturation. Moreover, we recorded drug doses, changes in infusion rates to ensure a desirable degree of sedation and adverse side effects. The maternal recall of delivery and satisfaction with sedation were also evaluated. Results: The incidence of increased sedative infusion rates was higher in the PROP group (59.3% vs. 37.9%). In contrast, decreased infusion rates were observed in the MID group (41.4% vs. 29.6%). After the initial dose, a desirable level of sedation was easier to obtain in the PROP group (77.7% vs. 55.1%), whereas excessive sedation was noted more frequently in the MID group (34.5% vs. 11.5%). The deepest degree of sedation was found in 2 PROP patients and 1 MID patient. In the PROP group, excessive sedation was rapidly alleviated by reducing the infusion rate. In the MID group, excessive sedation was observed throughout the examination, despite reduced infusion rates. No significant intergroup differences were found for desired sedation levels. The mean heart rate and arterial pressure were lower in the PROP group. In the MID group, only 5% of patients developed an elevated systolic RR. No ECG alterations were observed in any patient. A haemoglobin oxygen saturation level below 92% was found in 1 patient from each group. Logorrhoea was characteristic in the PROP group (44.4%). The incidence of nausea and vomiting were higher in the MID group. Other side effects (e.g., headache, backache, erythema and chills) were observed in a subset of patients from both groups. In the MID group, birth recall was significantly lower (82.8% vs. 96.3%). Full satisfaction with sedation was declared by 89.6% of MID patients and 92.6% of PROP patients. Conclusions: Midazolam and propofol induce effective and safe sedation in patients receiving subarachnoid anaesthesia for Caesarean section. Propofol appears to be more useful for Caesarean section sedation when compared with midazolam because of its shorter action, antiemetic effects and better maternal recall of foetal delivery.
The aim of the study was to assess the influence of general anesthesia on bacterial growth in bronchial tree, depending upon the applied method of anesthesia. The artificial airway is the additional gate for respiratory tract infections and mechanical ventilation which can have an influence on postoperative complications such as pneumonia and atelectasis. Patients undergoing 4h surgeries were sampled. Due to selection of anesthetics, volatile or intravenous, patients were divided into groups VGA (volatile general anesthesia) and TIVA (total intravenous anesthesia). Material collected with minibronchoalveolar lavage method directly after intubation and just before extubation. In 40% of all patients no bacteria growth was noted in both time points. In VGA group, from the bacteria cultured in 61.9% of patients in first sample, 62.5% of colonies diminished or eradicated, only 6.25% multiplied. In TIVA group 42.9% patients presented bacteria in first sample. All bacteria got reduced. Length of hospitalization preceding surgery (p=0.036) and number of smoked cigarettes (p=0.028) significantly correlated with colonization of bacteria. General anesthesia has no influence on the respiratory tract microorganism contamination and can even favour the eradication of the colonizing bacterial flora.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.